Maintenance Notice (4:30 AM - 11:00 AM December 21, 2024): This website is scheduled to be unavailable due to maintenance. We appreciate your patience and understanding.
Published TCIMAIL newest issue No.197
Maximum quantity allowed is 999
Please select the quantity
Endo-type Glycohydrolytic Enzymes "Endoglycosidase"
No.196(August 2024)
- A1651
- endo-β-N-Acetylglucosaminidase (=Endo-M) Recombinant: from Mucor hiemalis expressed in Candida boidinii (100m units/vial) (1)
- E1339
- Endo-M-W251N Recombinant: from Mucor hiemalis expressed in Escherichia coli (500m units/vial) (2)
- A1844
- endo-α-N-Acetylgalactosaminidase (=Endo-α) Recombinant: from Bifidobacterium longum expressed in Escherichia coli (3)
- R0240
- rEGCase I (4)
- R0241
- rEGCase I assisted by Activator II (5)
- K0069
- Keratanase II from Bacillus circulans, Recombinant (6)
Two types of glycosidases are known: "exo-type" which breaks down from the terminal end of a glycan chain, and "endo-type" which cuts out oligosaccharides from the middle of a glycan chain. TCI has lined up a variety of endoglycosidases for diverse glycan analyses (1-6). They are gene-recombinant glycosidases and are already available for practical use in large quantities. Please use them as sophisticated research tools for cutting-edge glycoscience.
1 was merchandised as the fruition of NEDO project under licenses from patent-holding companies of Takara Bio Inc. and Kirin Brewery Co., LTD.
2 was commercialized under license from Ishikawa Prefectural University.
3 was merchandised as the fruition of NEDO project.
4, 5, R0242 and R0243 were commercialized under license from Kyushu University.
6 was commercialized under license from Kansai Medical University.
Related Products
The prices are subject to change without notice. Please confirm the newest price by our online catalog before placing an order.
In addition, sales products changes with areas. Please understand that a product is not available when the product details page is not displayed.